Загрузка...
Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease
We conducted a phase I study investigating the efficacy, safety, and tolerability of ONO-2160, a newly developed levodopa pro-drug, and carbidopa compared with levodopa and carbidopa to stabilize levodopa plasma concentration fluctuations in Japanese patients with Parkinson's disease. In an ope...
Сохранить в:
| Опубликовано в: : | eNeurologicalSci |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6171046/ https://ncbi.nlm.nih.gov/pubmed/30294682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2018.09.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|